Long
CymaBay Therapeutics $CBAY - investment idea 💡
❌ - The volume is low on daily but increasing on 4h
✅ - We got double bottom on daily
✅ - We got Bullish engulfing action few days back on the lower channel at $5.64
✅ - MACD
✅ - STOCH
✅ - DeMarker
❌ - MA50 (13% under 50MA)
✅ - MA200 (6% above 200MA)
❌ - Pivots: (7% under the pivot point)
✅ - Ratings (7) buy
⏰ - Breakout 1: $6, Breakout 2: $6.40
🚀 - Potential targets (🚀+45%, 🚀🚀+81%, 🚀🚀🚀+107%)
🪂 - If things goes wrong better to exit under 5.62
🚦 - Next entries in case if dropped: $5.12, $4.20
⚠️ - This idea is based on my technical analysis only. Do your research and trade on your own risk!
--
Is CBAY A Good Stock To Buy Now?
finance.yahoo.com/news/cbay-good-stock-buy-now-030744478.html
CymaBay Therapeutics Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com/news/cymabay-therapeutics-nasdaq-cbay-good-042507833.html
✅ - We got double bottom on daily
✅ - We got Bullish engulfing action few days back on the lower channel at $5.64
✅ - MACD
✅ - STOCH
✅ - DeMarker
❌ - MA50 (13% under 50MA)
✅ - MA200 (6% above 200MA)
❌ - Pivots: (7% under the pivot point)
✅ - Ratings (7) buy
⏰ - Breakout 1: $6, Breakout 2: $6.40
🚀 - Potential targets (🚀+45%, 🚀🚀+81%, 🚀🚀🚀+107%)
🪂 - If things goes wrong better to exit under 5.62
🚦 - Next entries in case if dropped: $5.12, $4.20
⚠️ - This idea is based on my technical analysis only. Do your research and trade on your own risk!
--
Is CBAY A Good Stock To Buy Now?
finance.yahoo.com/news/cbay-good-stock-buy-now-030744478.html
CymaBay Therapeutics Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com/news/cymabay-therapeutics-nasdaq-cbay-good-042507833.html
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.